Want to join the conversation?
$ABT 2Q15 Call: Diagnostics achieved sales growth of 9%, driven by continued above-market performance in Core Lab and point-of-care diagnostics. In Nutrition, sales increased 4%, slightly below expectations. In Medical Devices, diabetics care delivered 5% growth. In Established Pharmaceuticals, sales increased double digits.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?